Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results
|
Evolent Health, Inc. (EVH)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
09/26/2023 |
8-K/A
| Quarterly results |
08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/09/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/04/2023 |
8-K/A
| Other Events Interactive Data |
08/02/2023 |
8-K
| Quarterly results |
07/26/2023 |
8-K
| Quarterly results |
07/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
06/12/2023 |
144
| Form 144 - Report of proposed sale of securities: |
06/12/2023 |
144
| Form 144 - Report of proposed sale of securities: |
06/12/2023 |
144
| Form 144 - Report of proposed sale of securities: |
06/08/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
06/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
05/26/2023 |
D
| Form D - Notice of Exempt Offering of Securities: |
05/23/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
05/08/2023 |
144/A
| Form 144/A - Report of proposed sale of securities: [Amend] |
05/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
05/03/2023 |
8-K
| Quarterly results |
04/26/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
04/19/2023 |
8-K
| Quarterly results |
03/29/2023 |
8-K
| Quarterly results |
03/08/2023 |
SC 13G/A
| UPMC reports a 2% stake in Evolent Health, Inc. |
02/24/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
02/22/2023 |
8-K
| Quarterly results |
02/14/2023 |
SC 13G/A
| Granahan Investment Management, LLC reports a 3.1% stake in EVOLENT HEALTH, INC |
02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 9.7% stake in Evolent Health Inc. Class A |
02/03/2023 |
SC 13G/A
| UPMC reports a 5.8% stake in Evolent Health, Inc. |
01/31/2023 |
SC 13G/A
| BlackRock Inc. reports a 7.6% stake in EVOLENT HEALTH, INC |
01/27/2023 |
SC 13G
| MAGELLAN HEALTH INC reports a 8.4% stake in Evolent Health, Inc. |
01/23/2023 |
8-K
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financia...
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549",
"Certificate of Designation of Series A Convertible Preferred Stock of Evolent Health, Inc.",
"Amendment No. 1, to the Credit Agreement, by the Lenders party thereto, EVH LLC, as the Administrative Borrower, the other borrowers party thereto, the Company, as the Parent, each other Guarantor party thereto, Ares Capital Corporation, as Administrative Agent, and ACF Finco I LP, as Collateral Agent and Revolving Agent",
"Securities Purchase Agreement, by and among the Purchasers listed on Schedule I thereto and Evolent Health, Inc",
"Investors Rights Agreement, by and among the Purchasers listed on Schedule I thereto and Evolent Health, Inc",
"Registration Rights Agreement, by and among the Stockholders named in Schedule I thereto and Evolent Health, Inc",
"Registration Rights Agreement, by and between Magellan Parent and Evolent Health, Inc",
"Lock Up Agreement, by and between Magellan Parent and Evolent Health, Inc",
"Consent of KPMG LLP, independent auditors for Magellan",
"Combined audited financial statements of Magellan as of December 31, 2021 and 2020 and for the two years ended December 31, 2021",
"Combined unaudited financial statements of Magellan as of September 30, 2022 and December 31, 2021 and for the nine months ended September 30, 2022 and 2021" |
|
01/20/2023 |
SC 13G/A
| JPMORGAN CHASE & CO reports a 5.3% stake in Evolent Health, Inc. |
01/11/2023 |
8-K
| Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits I... |
11/17/2022 |
8-K
| Quarterly results |
11/09/2022 |
8-K
| Quarterly results |
|
|
|